MenB-FHbp Meningococcal Group B Vaccine (Trumenba

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

18 citing papers in PubMed, 30 citations in OpenAlex.

1. Quadrivalent meningococcal tetanus toxoid-conjugate booster vaccination in adolescents and adults: phase III randomized study.Pediatric research · 2023
   Trial
2. Deposition of complement regulators on the surface of Plasmodium falciparum merozoites depends on the immune status of the host.PLoS pathogens · 2025
   Article
3. Characterisation and Immunogenicity ofFrontiers in immunology · 2024
   Article
4. Epidemiology, clinical features and outcome of adults with meningococcal meningitis: a 15-year prospective nationwide cohort study.The Lancet regional health. Europe · 2023
   Article
5. FHbp variants among meningococci of serogroup B in Italy: Evolution and selective pressure, 2014-2017.PloS one · 2023
   Article
6. AnInternational journal of molecular sciences · 2022
   Article
7. A Bacterially Expressed SARS-CoV-2 Receptor Binding Domain Fused With Cross-Reacting Material 197 A-Domain Elicits High Level of Neutralizing Antibodies in Mice.Frontiers in microbiology · 2022
   Article
8. Frontiers in bioengineering and biotechnology · 2022
   Review
9. Engineered Remolding and Application of Bacterial Membrane Vesicles.Frontiers in microbiology · 2021
   Review
10. Interactions Between PathogenicFrontiers in cellular and infection microbiology · 2021
    Review
11. Why the Anti-Meningococcal B Vaccination during Adolescence Should Be Implemented in Italy: An Overview of Available Evidence.Microorganisms · 2020
    Review
12. Bioinformatics prediction and experimental validation of VH antibody fragment interacting withIranian journal of basic medical sciences · 2020
    Article
13. Immunogenicity of trimeric autotransporter adhesins and their potential as vaccine targets.Medical microbiology and immunology · 2020
    Review
14. Meningococcal B vaccine antigen FHbp variants among disease-causing Neisseria meningitidis B isolates, Italy, 2014-2017.PloS one · 2020
    Article
15. [Health Technology Assessment of meningococcal B vaccine (TrumenbaJournal of preventive medicine and hygiene · 2019
    Article
16. Meningococcal pneumonia: a review.Pneumonia (Nathan Qld.) · 2019
    Review
17. A new meningococcal B vaccine for adolescents and adults: characteristics and methods of use.Journal of preventive medicine and hygiene · 2018
    Article
18. Global epidemiology of serogroup B meningococcal disease and opportunities for prevention with novel recombinant protein vaccines.Human vaccines & immunotherapeutics · 2018
    Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors at 2 institutions in 2 countries.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as